Clear Harbor Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.06M Sell
8,705
-167
-2% -$59.5K 0.21% 96
2025
Q4
$2.9M Buy
8,872
+66
+0.7% +$20.9K 0.2% 102
2025
Q3
$2.49M Sell
8,806
-435
-5% -$126K 0.17% 108
2025
Q2
$2.58M Sell
9,241
-275
-3% -$77.9K 0.19% 97
2025
Q1
$2.96M Buy
9,516
+145
+2% +$42.8K 0.23% 85
2024
Q4
$2.44M Buy
9,371
+104
+1% +$30.9K 0.19% 96
2024
Q3
$2.99M Buy
9,267
+1
+0% +$327 0.24% 86
2024
Q2
$2.9M Sell
9,266
-94
-1% -$27.6K 0.25% 85
2024
Q1
$2.66M Sell
9,360
-381
-4% -$111K 0.23% 91
2023
Q4
$2.81M Sell
9,741
-11
-0.1% -$3K 0.26% 81
2023
Q3
$2.62M Buy
9,752
+1
+0% +$250 0.27% 81
2023
Q2
$2.16M Buy
9,751
+1,943
+25% +$451K 0.21% 95
2023
Q1
$1.89M Buy
7,808
+2,623
+51% +$644K 0.19% 106
2022
Q4
$1.36M Sell
5,185
-50
-1% -$13.4K 0.17% 108
2022
Q3
$1.18M Sell
5,235
-20
-0.4% -$4.85K 0.16% 108
2022
Q2
$1.28M Sell
5,255
-3
-0.1% -$735 0.17% 105
2022
Q1
$1.27M Sell
5,258
-700
-12% -$161K 0.14% 131
2021
Q4
$1.34M Sell
5,958
-37
-0.6% -$7.81K 0.15% 122
2021
Q3
$1.27M Sell
5,995
-45
-0.7% -$10.4K 0.02% 139
2021
Q2
$1.47M Sell
6,040
-50
-0.8% -$12.3K 0.18% 109
2021
Q1
$1.51M Sell
6,090
-290
-5% -$69.2K 0.2% 100
2020
Q4
$1.47M Sell
6,380
-957
-13% -$221K 0.21% 84
2020
Q3
$1.86M Buy
7,337
+8
+0.1% +$1.98K 0.32% 61
2020
Q2
$1.73M Buy
7,329
+884
+14% +$202K 0.33% 58
2020
Q1
$1.31M Buy
6,445
+60
+0.9% +$13.1K 0.3% 66
2019
Q4
$1.54M Hold
6,385
0.27% 69
2019
Q3
$1.24M Buy
6,385
+49
+0.8% +$9.4K 0.24% 83
2019
Q2
$1.17M Sell
6,336
-30
-0.5% -$5.37K 0.24% 76
2019
Q1
$1.21M Sell
6,366
-470
-7% -$89.8K 0.25% 76
2018
Q4
$1.33M Buy
6,836
+33
+0.5% +$6.44K 0.31% 65
2018
Q3
$1.28M Sell
6,803
-86
-1% -$16.9K 0.26% 74
2018
Q2
$1.27M Sell
6,889
-170
-2% -$30.1K 0.24% 82
2018
Q1
$1.2M Buy
7,059
+801
+13% +$147K 0.24% 82
2017
Q4
$1.09M Buy
6,258
+145
+2% +$25.7K 0.2% 94
2017
Q3
$1.14M Sell
6,113
-36
-0.6% -$6.38K 0.23% 87
2017
Q2
$1.06M Sell
6,149
-136
-2% -$22.1K 0.2% 95
2017
Q1
$1.03M Hold
6,285
0.21% 96
2016
Q4
$919K Buy
6,285
+660
+12% +$99.3K 0.19% 90
2016
Q3
$938K Sell
5,625
-150
-3% -$25.4K 0.2% 92
2016
Q2
$879K Buy
5,775
+3,322
+135% +$516K 0.19% 97
2016
Q1
$368K Hold
2,453
0.08% 160
2015
Q4
$398K Hold
2,453
0.09% 155
2015
Q3
$339K Hold
2,453
0.08% 182
2015
Q2
$377K Buy
2,453
+461
+23% +$73.8K 0.07% 190
2015
Q1
$318K Hold
1,992
0.06% 213
2014
Q4
$317K Hold
1,992
0.06% 209
2014
Q3
$280K Hold
1,992
0.06% 173
2014
Q2
$236K Hold
1,992
0.05% 183
2014
Q1
$246K Hold
1,992
0.06% 175
2013
Q4
$227K Hold
1,992
0.06% 159
2013
Q3
$223K Buy
+1,992
New +$216K 0.06% 154

Other funds holding AMGN

Clear Harbor Asset Management's AMGN Position: Q1 2026 in Review

Clear Harbor Asset Management reduced its Amgen (AMGN) stake by 1.9% in Q1 2026, selling an estimated $59.5K and leaving 8,705 shares worth $3.06M. The position accounts for 0.21% of the portfolio, ranked #96.

Clear Harbor Asset Management first reported a position in AMGN in Q3 2013 and has held it in 51 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Clear Harbor Asset Management held 8,705 shares of Amgen worth $3.06M as of Q1 2026.
  • Clear Harbor Asset Management sold 167 Amgen shares in Q1 2026, an estimated $59.5K.
  • Amgen made up 0.21% of Clear Harbor Asset Management's portfolio in Q1 2026, its #96 holding.
  • Clear Harbor Asset Management first reported a position in Amgen in Q3 2013 and has held it in 51 quarters since.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Clear Harbor Asset Management's 13F filing for Q1 2026, filed 5 May 2026.